HOME >> BIOLOGY >> NEWS
Renowned author, scientist and professor, John L. Casti, returns to IIASA

March 31, 2000 - LAXENBURG, Austria - The International Institute for Applied Systems Analysis is pleased to announce that renowned author, scientist and professor, John Casti, Ph.D. has rejoined the IIASA staff as a general research scholar. Dr. Casti, who became a member of IIASA's scientific team in 1974, was with the world-renowned research institute until 1986. During his career, Casti authored eleven books, the most recent of which are, Paradigms Regained and Five More Golden Rules - Knots, Codes, Chaos, and Other Great Theories of 20th-Century Mathematics. Casti also holds a professorship at both The Santa Fe Institute, located in Santa Fe, New Mexico, and at the Technical University of Vienna, in Vienna, Austria. He also consults with the Austrian National Research Center in Seibersdorf, Austria.

At IIASA, Casti will apply his expertise in developing mathematical modeling to three research objectives: charting topography of Internet usage, modeling risks associated with the world's natural catastrophes, and developing mathematical and conceptual techniques to understand the evolution of complex adaptive systems. Casti will team with three of the 14 current projects at IIASA: Natural Catastrophes and Developing Countries (CAT), Risk, Modeling and Society (RMS), and Adaptive Dynamics Network (ADN).

In Five More Golden Rules, like its critically acclaimed predecessor, Five Golden Rules, Casti reveals the remarkable origins of some of the most monumental mathematical discoveries of the last century and sheds light on how these revolutionary ideas have reshaped our lives. In Paradigms Regained, a sequel to Paradigms Lost, gives a layman's account of several of the most puzzling controversies in modern science. He also authored Would-Be Worlds and The Cambridge Quintet.

IIASA is an independent, non-governmental, interdisciplinary research institution, which specializes in natural and social scientific research methods and models for use
'"/>

Contact: Karen Gerwitz
gerwitz@iiasa.ac.at
43-2236-807-370
International Institute for Applied Systems Analysis
30-Mar-2000


Page: 1 2

Related biology news :

1. Renowned yeast and human geneticist at UCSF receives major research honor
2. Renowned Prostate Cancer Experts Present Latest Findings At UCSF Cancer Center Symposium
3. Renowned Breast Cancer Experts Present Latest Findings At UCSF Cancer Center Symposium
4. 16th Annual Depression Symposium features Pulitzer Prize-winning author, world-renowned neurosurgeon
5. EMBO Gold Medal 2004 goes to Spanish scientist
6. DNA lends scientists a hand, revealing new chemical reactions
7. UCSF scientist Joe Derisi named MaCarthur Fellow
8. Conference at UH opens doors for new scientists, engineers
9. Wisconsin scientists develop quick botox test
10. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
11. Alaska scientists find Arctic tundra yields surprising carbon loss

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Renowned author scientist and professor John Casti returns IIASA

(Date:1/22/2015)... 2015  Today, FreeWavz ( www.FreeWavz.com ), the developer ... on Fundable, https://www.fundable.com/freewavz . FreeWavz will be ... to meet customer demand. Logo - ... Invented by Dr. ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... 2015  Analyst Report Issued by Small Cap IR. In 2011, ... planet-wide, transactions at merchants on the leading payment cards rose ... credit, debit, and prepaid cards reached 6.54 billion.  Eight million ... card usage in 2012, and credit and debit card fraud ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
(Date:2/27/2015)... and SUMMERLAND, British Columbia , ... XON ), a leader in synthetic biology, ... acquire  Okanagan Specialty Fruits (OSF), the pioneering agricultural ... the world,s first non-browning apple. Through the acquisition, Intrexon ... that is more appetizing and convenient for consumers while ...
(Date:2/27/2015)... Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... studies for its newly developed Bruton,s tyrosine kinase ... been completed. The results of these preclinical evaluations ... Drug Administration. The feedback received from the Agency ... first-in-human study. Additional preclinical work is required to ...
(Date:2/27/2015)... A paper published today, " Financing ... in Science Translational Medicine, demonstrates the ... the risk associated with investing in the treatment ... of funding for developing so-called "orphan" drugs. ... between scientists at the National Center for Advancing ...
(Date:2/27/2015)... , Feb. 27, 2015 Research and Markets ... "Global Market Report of Trypsin" report to their offering. ... 9002-07-7) aims at providing comprehensive data on Trypsin globally and ... , North America , Latin ... close attention to Trypsin This report focuses on ...
Breaking Biology Technology:Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Global Market Report of Trypsin 2014-2018 2
Cached News: